Perfil de internamentos obstétricos no Amapá pela Covid-19
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Identificar as características clínicas e epidemiológicas de gestantes diagnosticadas com covid-19, em um município do estado do Amapá. Métodos: Trata-se de um estudo descritivo retrospectivo. A amostra foi composta por 18 gestantes com covid-19, atendidas no Hospital Universitário do Amapá, entre junho e dezembro de 2020. A coleta de dados foi realizada em prontuários, analisando as variáveis sociodemográficas, sinais e sintomas da covid-19, tipo de parto, internação em Unidade de Terapia Intensiva e desfecho materno e neonatal. Resultados: A idade média das gestantes foi de 25,2 anos, a maioria era parda, com ensino médio completo e dona de casa. As comorbidades mais evidenciadas foram hipertensão arterial sistêmica e obesidade. As complicações maternas mais observadas foram a pré-eclâmpsia e eclâmpsia, e quase metade das gestantes necessitaram de Unidade de Terapia Intensiva (UTI). Foram registrados três óbitos maternos. Conclusão: Gestantes com comorbidades, no terceiro trimestre de gestação, apresentaram desconforto respiratório com necessidade de cuidados intensivos e desfechos desfavoráveis.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. AMAPÁ. Governo do Estado do Amapá. 2020. Termo de cessão de uso de espaço físico que entre si celebram a Universidade Federal do Amapá e o Governo do Estado do Amapá, de 08 de maio de 2020. Disponível em: http://www.unifap.br/wp-content/uploads/2020/05/NEPCREAP_008319.pdf. Acessado em: 08 de abril de 2023.
3. ANDREAS NJ, et al. Human breast milk: A review on its composition and bioactivity. Early human development, 2015; 91(11): 629-635.
4. BADR DA, et al. Severe acute respiratory syndrome coronavirus 2 and pregnancy outcomes according to gestational age at time of infection. Emerging infectious diseases, 2021; 27(10): 2535-2543.
5. BARBOSA FILHO MC, et al. Síndrome respiratória aguda grave por COVID-19: perfil epidemiológico em gestantes e puérperas no Amazonas. Medicina (Ribeirão Preto), 2022; 55(2).
6. CIRELLI JF, et al. The Burden of Indirect Causes of Maternal Morbidity and Mortality in the Processof Obstetric Transition: A Cross-Sectional Multicenter Study. International Journal of Gynecology & Obstetrics, 2018; 40: 106-114.
7. DASHRAATH P, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American journal of obstetrics and gynecology, 2020; 222(6): 521-531.
8. DONZELLI M, et al. Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19. Clinical case reports, 2020; 8(12): 3351-3357.
9. FIOCRUZ, 2020. Monitoramento de casos de síndrome respiratória aguda grave (SRAG) notificados no SIVEP-Gripe. Disponível em: http://info.gripe.fiocruz.br/. Acessado em: 7 de maio de 2020.
10. GORBALENYA AE, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020; 5(4): 536–544.
11. GROULX T, et al. Prenatal care disruptions and associations with maternal mental health during the COVID-19 pandemic. Frontiers in Global Women's Health, 2021; 2: 648428.
12. HALSCOTT T, et al. Society for maternal-fetal medicine management considerations for pregnant patients with COVID-19. SFMF Guideline, 2020: 2021: 7-26.
13. HUAMAN YR, et al. Clinical characteristics and sociodemographic factors associated with COVID-19 infection in pregnant women in a maternal and children's public hospital. Medwave, 2021; e8442-e8442.
14. ISAAC B, et al. Maternal and Fetal Outcome in Pregnant Women With Critical COVID-19 Treated With Tocilizumab in a Tertiary Care Hospital in Dubai. Cureus, 2023; 15(1).
15. KHAN MMA, et al. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. MedRxiv, 2020; 03(31): 20049304.
16. MASUD SB, et al. Adverse birth outcomes among pregnant women with and without COVID-19: A comparative study from Bangladesh. Journal of preventive medicine and public health, 2021; 54(6): 422.
17. MENDONÇA CV, et al. Olfactory dysfunction in COVID-19: a marker of good prognosis? Brazilian Journal of Otorhinolaryngology, 2022; 88: 439-444.
18. MENDOZA M, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. An International Journal of Obstetrics and Gynaecology, 2020; 127(11): 1374-1380.
19. ORELLANA JDY, et al. Excess deaths during the COVID-19 pandemic: underreporting and regional inequalities in Brazil. Cad. Saúde Pública (Online), 2021; e00259120-e00259120.
20. PRADO MFD, et al. Análise da subnotificação de COVID-19 no Brasil. Revista Brasileira de Terapia Intensiva, 2020; 32: 224-228.
21. QEADAN F, et al. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC pregnancy and childbirth, 2021; 21: 1-14.
22. SAN-JUAN R, et al. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinical Medicine, 2020; 23: 100407.
23. SERRA FE, et al. COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women. PLoS One, 2021; 16(11): e0259911.
24. SHI Y, et al. An overview of COVID-19. Journal of Zhejiang University. Science. B, 2020; 1.
25. SONG F, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020; 295(1): 210-217.
26. VIVANTI AJ, et al. Retrospective description of pregnant women infected with severe acute respiratory syndrome coronavirus 2, France. Emerging Infectious Diseases, 2020; 26(9): 2069.
27. WENG LM, et al. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. Journal of Pain Research, 2021; 147-159.
28. WONG YP, et al. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics, 2021; 11(1): 94.
29. YAN J, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. American journal of obstetrics and gynecology, 2020; 223(1): 111. e1-111. e14.
30. YANG R, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC medicine, 2020; 18(1): 1-7.
31. ZOLDAN C, et al. Clinical course of pregnant women with SARS-CoV-2 infection with development of COVID-19: na integrative literature review. Research, Society and Development, 2021; 10(13).